TABLE 1

Summary of kinetic values of As(GS)3 transport by WT-MRP1, SF-MRP1, and Asn19/23Gln-MRP1–enriched membrane vesicles from HeLa and HEK293 cells prepared in the presence or absence of a phosphatase inhibitor cocktail (PIC)

Km ± S.D. (μM)aVmax ± S.D. (pmol mg−1 min−1)N
HeLa
 WT-MRP10.32 ± 0.03*42 ± 17**4
 WT-MRP1 + PIC6.0 ± 1.3505 ± 2923
 SF-MRP10.3 ± 0.1*44 ± 15**5
 SF-MRP1 + PIC3.2 ± 1.4609 ± 2515
HEK293
 WT-MRP13.8 ± 1.2307 ± 1188
 WT-MRP1 + PIC3.6 ± 0.8270 ± 1564
 SF-MRP10.6 ± 0.4*38 ± 21**4
 SF-MRP1 + PIC3.3 ± 1.8195 ± 815
 N19/23Q-MRP10.5 ± 0.2*37 ± 9**3
 N19/23Q-MRP1 + PIC4.2 ± 1.6300 ± 1746
  • HEK, human embryonic kidney 293 (cell line); MRP1, multidrug resistance protein 1; SF, sugar-free; WT, wild-type.

  • a Vmax values were corrected for levels of WT-MRP1, SF-MRP1, and Asn19/23Gln relative to HEK-WT-MRP1 using densitometry (ImageJ Software) analysis of at least three different immunoblots (see Supplemental Table 2).

  • * Km value significantly different (P < 0.01) from HEK-WT-MRP1 (one way analysis of variance, Dunnett’s multiple comparison test).

  • ** Vmax value significantly different (P < 0.01) than for HEK-WT-MRP1 (one way analysis of variance, Dunnett’s multiple comparison test).